CGP testing using tumor tissue and or peripheral blood samples is performed in patients with solid tumors before completion of standard therapy including those expected to complete standard therapy, a

3 trials

Sponsors

Yamamoto Noboru, Tamura Kenji, Tokushima University

Conditions

Solid Tumor comprehensive genomic profilingSolid tumors Solid tumors before completion of standard therapysolid cancer

Unknown Phase

Comprehensive Genomic Profilings in Solid Tumor Patients before Completion of Standard Therapy(NCCH2409 FORESIGHT)

RecruitingJPRN-jRCT1032250660

Yamamoto NoboruSolid Tumor comprehensive genomic profiling

Start: 2026-01-29Target: 600Updated: 2026-09-14

Comprehensive cancer genomic profiling in solid tumor patients before completion of standard therapy

Active, not recruitingJPRN-jRCT1062260005

Tamura KenjiSolid tumors Solid tumors before completion of standard therapy

Start: 2026-06-17Target: 30Updated: 2026-06-29

Comprehensive cancer genomic profiling before completion of standard therapy

Active, not recruitingJPRN-UMIN000062248

Tokushima Universitysolid cancer

Start: 2026-09-01Target: 500Updated: 2026-09-14